凯发官方首页 资讯 财经 公益 彩店 奇闻 速递 体育 提点

凯发官方首页
凯发官方首页
你现在的位置:
食品--

每日观察!欧盟评估贝莱斯芽孢杆菌nrrl b-凯发官方首页

2022-12-22 11:09:02    来源:    作者:


(资料图片)

    2022年12月20日,据欧盟食品安全局(efsa)消息,应欧盟委员会要求,欧盟动物饲料添加剂和产品(feedap)研究小组就贝莱斯芽孢杆菌(bacillus velezensis)nrrl b-67259作为所有生长中家禽物种饲料添加剂的有效性发表科学意见。

经过评估,专家小组无法就贝莱斯芽孢杆菌nrrl b-67259作为所有生长中家禽物种饲料添加剂的功效做出结论。部分原文报道如下:

following a request from the european commission, efsa was asked to deliver a scientific opinion on the efficacy of a product consisting of spores of bacillus velezensis nrrl b-67257 as a zootechnical additive for chickens for fattening, chickens reared for laying, turkeys for fattening, turkeys reared for breeding and minor poultry species. the additive has the tradename correlink™ abs1781 bacillus subtilis and is not currently authorised in the eu. it is intended for use in complete feed for the target species at a minimum inclusion level of 1.5 × 108cfu/kg complete feed. in a previous opinion, the feedap panel could not conclude on the efficacy of the additive for the poultry species due to the potential cross-contamination of the control diets in two of the three studies provided. the applicant has provided supplementary information to exclude this possibility. the new data showed that the gene used as marker in the previous analyses is non-specific of the nrrl b-67259 strain, which precluded the adequate quantification of the active agent in the feeds used in the studies. moreover, in a second analysis, the active agent could not be isolated from the field excreta samples collected from either the treated or the control group in the two formerly submitted efficacy studies. the panel concluded that the methodology was not able to discriminate between the strain under assessment and the background. additionally, two new efficacy trials with chickens for fattening were provided to support the efficacy of the additive. however, none could be further considered since the husbandry conditions in which the birds were kept were non-compliant with directive 2007/43/ec. therefore, the feedap panel was not in the position to conclude on the efficacy of correlink™ abs1781 for all growing poultry species.

编辑:qysb005

标签: 芽孢杆菌

中国企业新闻网凯发首页的版权与免责声明:
1、中国企业新闻网所有内容的凯发首页的版权均属于作者或页面内声明的凯发首页的版权人。未经中国企业新闻网的书面许可, 任何其他个人或组织均不得以任何形式将河南企业网的各项资源转载、复制、编辑或发布使用于其他任何场合;不得把其中任何形式的资讯散发给其他方, 不可把这些信息在其他的服务器或文档中作镜像复制或保存;不得修改或再使用中国企业新闻网的任何资源。若有意转载本站信息资料, 必需取得中国企业新闻网书面授权。否则将追究其法律责任。
2、已经本网授权使用作品的,应在授权范围内使用,并注明“来源:中国企业新闻网”。违反上述声明者,本网将追究其相关法律责任。
3、凡本网注明“来源:xxx(非中国企业新闻网)”的作品,均转载自其它媒体,转载目的在于传递更多信息, 并不代表本网赞同其观点和对其真实性负责。本网转载其他媒体之稿件,意在为公众提供免费服务。如稿件凯发首页的版权单位或个人不想在本网发布, 可与本网联系,本网视情况可立即将其撤除。
图片欣赏
频道推荐
内容推荐
最近更新

  凯发官方首页 copyright @ 2001-2013 凯发官方首页-凯发首页 all rights reserved 企业时报 凯发首页的版权所有

  网站所登新闻、资讯等内容, 均为相关单位具有著作权,转载注明出处

联系网站:[email protected]

"));
网站地图